AKT1 and cancer: Our results demonstrate that NLRX1 diminishes the cancer-associated phenotypes of Pan02 cells and protects against cancer-associated biological functions through the regulation of NF-κB, MAPK, AKT, inflammasome, and immune recognition/activation signaling.